| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2009 | US20090170799 Chimeric oligonucleotide for use in diagnosis and treatment of tissue destruction, necrosis and inflammatory diseases |
| 07/02/2009 | US20090170798 Highly safe intranasally administrable gene vaccines for treating alzheimer's disease |
| 07/02/2009 | US20090170797 Hunk, a snfi-related kinase essential for mammary tumor metastasis |
| 07/02/2009 | US20090170796 Histone Demethylation Mediated By The Nuclear Amine Oxidase Homolog LSD1 |
| 07/02/2009 | US20090170795 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 07/02/2009 | US20090170794 Small interfering rnas that efficiently inhibit viral expression and methods of use thereof |
| 07/02/2009 | US20090170793 Theophylline-dependent riboswitches which modulate RNA splicing; made by insertion of a high affinity theophylline binding aptamer into the 3' splice site region, 5' splice site region, or branchpoint sequence (BPS) of a pre-mRNA modulates RNA splicing in the presence of theophylline |
| 07/02/2009 | US20090170792 Peptide ligands |
| 07/02/2009 | US20090170791 Macrolones |
| 07/02/2009 | US20090170790 Ketolide derivatives as antibacterial agents |
| 07/02/2009 | US20090170789 Antioxidants for preventing and treating diseases caused by oxidative stress |
| 07/02/2009 | US20090170788 Novel use of 1, 2, 3, 4, 6-penta-o-galloyl-beta-d-glucose |
| 07/02/2009 | US20090170776 Angiogenically effective unit dose of fgf and method of administering |
| 07/02/2009 | US20090170773 Novel use of g-protein-conjugated receptor and ligand thereof |
| 07/02/2009 | US20090170768 Water-soluble carbon nanotube compositions for drug delivery and medicinal applications |
| 07/02/2009 | US20090170765 Peptide for inhibition of calcineurin |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170758 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
| 07/02/2009 | US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R) |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives |
| 07/02/2009 | US20090170161 GDEP Enhancer Element and Use Thereof to Confer Retinal Specific Gene Expression |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170098 Antibodies to cell-cycle regulatory protein p16, and uses related thereto |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169644 Antidandruff Shampoo |
| 07/02/2009 | US20090169638 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 07/02/2009 | US20090169633 Oral particle including pseudoephedrine hydrochloride and cetirizine dihydrochloride |
| 07/02/2009 | US20090169632 Sustained release composition and manufacturing method thereof |
| 07/02/2009 | US20090169629 Micellar compositions with ophthalmic applications |
| 07/02/2009 | US20090169628 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/02/2009 | US20090169627 Particles for injection and processes for forming the same |
| 07/02/2009 | US20090169626 Tamper resistant dosage forms |
| 07/02/2009 | US20090169625 Electrostatically Controlled Hydrogels |
| 07/02/2009 | US20090169624 Observing elution of compound from matrix comprising buffered detergents; assessing and controlling manufacturing process variability of drug eluting implantable devices such as cardiac leads |
| 07/02/2009 | US20090169623 Use of ginsenosides and extracts containing them |
| 07/02/2009 | US20090169622 Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
| 07/02/2009 | US20090169621 Pharmaceutical excipient having improved compressibility |
| 07/02/2009 | US20090169620 Orally disintegrating tablet compositions of temazepam |
| 07/02/2009 | US20090169619 Carbamazepine extended release dosage form |
| 07/02/2009 | US20090169618 Zolpidem pharmaceutical compositions |
| 07/02/2009 | US20090169616 Formulation and method for the release of paroxetine in the large intestine |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169608 Topically applicable composition for use as a skin bleaching agent |
| 07/02/2009 | US20090169606 Low Flexural Strength Transdermal Tobacco Alkaloid Patch |
| 07/02/2009 | US20090169605 Novel Tape Preparation |
| 07/02/2009 | US20090169604 Adhesive Pharmaceutical Preparation Containing Bisoprolol |
| 07/02/2009 | US20090169601 Transdermal Therapeutic System for Administering Lipophilic and/or Sparingly Skin- Permeable Active Substances |
| 07/02/2009 | US20090169595 Controlled Release Polymeric Compositions of Bone Growth Promoting Compounds |
| 07/02/2009 | US20090169591 Medical articles for the treatment of tumors |
| 07/02/2009 | US20090169587 Chronotherapeutic dosage forms |
| 07/02/2009 | US20090169585 Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169583 Solid Adsorbates of Hydrophobic Drugs |
| 07/02/2009 | US20090169573 T-Cell Stimulatory Peptides From The Melanoma-Associated Chondroitin Sulfate Proteoglycan And Their Use |
| 07/02/2009 | US20090169571 Selected ma motifs to include cell death and/or apoptosis |
| 07/02/2009 | US20090169567 Basic group-containing compound and use thereof |
| 07/02/2009 | US20090169566 Bioactive compositions |
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169560 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 07/02/2009 | US20090169558 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 07/02/2009 | US20090169557 Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies |
| 07/02/2009 | US20090169554 Polypeptides of Leishmania Major and Polynucleotides Encoding Same and Vaccinal, Therapeutical and Diagnostic Applications Thereof |
| 07/02/2009 | US20090169548 Binding molecules |
| 07/02/2009 | US20090169545 5-ht4 receptor antagonists for the treatment of heart failure |
| 07/02/2009 | US20090169542 Modulators of neuronal regeneration |
| 07/02/2009 | US20090169540 Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy |
| 07/02/2009 | US20090169535 Treatment of epilepsy by expressing st3gal-iii |
| 07/02/2009 | US20090169533 Compositions and methods for treating neurodegenerative diseases |
| 07/02/2009 | US20090169529 Compositions and methods for immunostimulatory rna oligonucleotides |
| 07/02/2009 | US20090169520 Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril Formation |
| 07/02/2009 | US20090169514 Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy |
| 07/02/2009 | US20090169511 Mucosal Bioadhesive SLow Release Carrier for Delivering Active Principles |
| 07/02/2009 | US20090169508 Opioid and opioid-like compounds and uses thereof |
| 07/02/2009 | US20090169507 Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 07/02/2009 | US20090169506 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/02/2009 | US20090169504 Compounds and Pharmaceutical compositions for the treatment of Viral infections |
| 07/02/2009 | US20090169498 Controlled Release Gels |
| 07/02/2009 | US20090169497 Treatment and Prevention of Skin Injury Due to Exposure to Ultraviolet Light |
| 07/02/2009 | US20090169495 such as 2-{3-[Bis-(2-ethyl-hexyl)-amino]-cyclohex-2-enylidene}-malononitrile, used for the protection of human hair and skin against the damaging effect of ultraviolet radiation; sunscreen agents; cosmetics |
| 07/02/2009 | US20090169490 Composition and method for weight loss |
| 07/02/2009 | US20090169489 Cobalamin compositions and methods for treating or preventing mucositis |
| 07/02/2009 | US20090169485 Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer |
| 07/02/2009 | US20090169484 Iron-salen complex |
| 07/02/2009 | US20090169479 Compounds Comprising Short Aminoalcohol Chains and Metal Complexes for Medical Imgaing |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | US20090169472 Methods and compositions for treating immune disorders |
| 07/02/2009 | US20090165723 Methods of producing avian eggs and birds of specified germ-free status |
| 07/02/2009 | DE202008016055U1 Kosmetische oder medizinische Zubereitung enthaltend Biotin Cosmetic or medicinal preparation containing biotin |
| 07/02/2009 | DE202008010019U1 Pharmazeutische Formulierung von Kontrastmitteln A pharmaceutical formulation of contrast agents |
| 07/02/2009 | DE102007063503A1 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17-hydroxy-19-nor-21-carboxylic acid y-lactone steroid derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | DE102007063501A1 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15, 16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone steroid derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | DE102007063500A1 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | DE102007063499A1 Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel Steroid-17,17-lactol derivative, the use of the derivative and pharmaceutical compositions containing them |
| 07/02/2009 | DE102007063498A1 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15,16-methylene steroid-17,17-lactol derivative, the use of the derivative and pharmaceutical compositions containing them |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/02/2009 | DE102007053369A1 Use of a preparation containing a creatine-component and a further component of e.g. L-carnitine, acetyl-L-carnitine, arginine, glutathione, vitamin C and vitamin E, as a dietary supplement for improving the male fertility in vertebrates |
| 07/02/2009 | CA2715203A1 Antitumoral compounds |
| 07/02/2009 | CA2712414A1 Pharmaceutical composition |